Abstract
Background and Aims: Increased fish oil consumption has been associated with a lower risk of cardiovascular disease (CVD). Fish oils owe their CVD benefits to omega-3 fatty acids which include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Multiple clinical trials, with the majority of them administering a combination of EPA and DHA, have been conducted in Western and Asian populations with mixed outcomes. This study aimed to determine whether omega-3 fatty acid formulations of EPA alone versus mixed combinations can confer protection in patients with CVD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
